Local delivery of hydrogel encapsulated vascular endothelial growth factor for the prevention of medication-related osteonecrosis of the jaw
Abstract The anti-angiogenic effects of bisphosphonates have been hypothesized as one of the major etiologic factors in the development of medication-related osteonecrosis of the jaw (MRONJ), a severe debilitating condition with limited treatment options. This study evaluated the potential of a gela...
Guardado en:
Autores principales: | Dileep Sharma, Stephen Hamlet, Cedryck Vaquette, Eugen Bogdan Petcu, Poornima Ramamurthy, Saso Ivanovski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d782f552cb58469489bc6a25f0820bd4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Mechanosensing and Global DNA Methylation of Human Osteoblasts on MEW Fibers
por: Pingping Han, et al.
Publicado: (2021) -
Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw
por: Pei-I Kuo, et al.
Publicado: (2021) -
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients
por: Sakiko Soutome, et al.
Publicado: (2021) -
Osteonecrosis of the Jaws in Patients Receiving Anti-Angiogenic Drugs and Chemotherapeutics: Literature Review and Case Reports
por: Mihaylova Z., et al.
Publicado: (2019) -
Refractory healing after surgical therapy of osteonecrosis of the jaw: associated risk factors in aged patients
por: Kim JY, et al.
Publicado: (2019)